Imricor Medical Systems, Inc. (ASX:IMR)

Australia flag Australia · Delayed Price · Currency is AUD
1.700
+0.035 (2.10%)
Jun 5, 2025, 4:10 PM AEST
277.78%
Market Cap 544.55M
Revenue (ttm) 1.55M
Net Income (ttm) -47.98M
Shares Out 320.33M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 199,796
Average Volume 359,455
Open 1.690
Previous Close 1.665
Day's Range 1.640 - 1.770
52-Week Range 0.410 - 1.860
Beta -0.33
RSI 56.16
Earnings Date Aug 26, 2025

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to min... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Country United States
Stock Exchange Australian Securities Exchange
Ticker Symbol IMR
Full Company Profile

Financial Performance

In 2024, Imricor Medical Systems's revenue was $959,424, an increase of 55.86% compared to the previous year's $615,568. Losses were -$29.69 million, 31.2% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.